GT Biopharma
GTBP
GTBP
16 hedge funds and large institutions have $35.3M invested in GT Biopharma in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
+$5.36M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.84K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$11.7K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.22K |
| 4 |
BlackRock
New York
|
-$72 |
| 5 |
FRA
Front Row Advisors
Tiburon,
California
|
-$3 |
